pd 98059 and ginsenoside rh1

pd 98059 has been researched along with ginsenoside rh1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, YJ; Lee, SG; Yoon, JH	1

Other Studies

1 other study(ies) available for pd 98059 and ginsenoside rh1

Article	Year
Ginsenoside Rh1 suppresses matrix metalloproteinase-1 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathway in human hepatocellular carcinoma cells. European journal of pharmacology, 2012, Mar-15, Volume: 679, Issue:1-3 Topics: Anthracenes; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Flavonoids; Ginsenosides; Hep G2 Cells; Humans; Matrix Metalloproteinase 1; Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Signal Transduction; Tetradecanoylphorbol Acetate; Time Factors; Transcription Factor AP-1	2012

Article

Year

Ginsenoside Rh1 suppresses matrix metalloproteinase-1 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathway in human hepatocellular carcinoma cells.

European journal of pharmacology, 2012, Mar-15, Volume: 679, Issue:1-3

Topics: Anthracenes; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Flavonoids; Ginsenosides; Hep G2 Cells; Humans; Matrix Metalloproteinase 1; Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Signal Transduction; Tetradecanoylphorbol Acetate; Time Factors; Transcription Factor AP-1

2012